AEON Biopharma
AEON
AEON
37 hedge funds and large institutions have $4.8M invested in AEON Biopharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+7
Holders Change %
+23.33%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$162K |
2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$27K |
3 |
VF
Virtu Financial
New York
|
+$21K |
4 |
TSS
Two Sigma Securities
New York
|
+$13.2K |
5 |
HF
HRT Financial
New York
|
+$11K |
Top Sellers
1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$452K |
2 |
BOCH
Blue Owl Capital Holdings
New York
|
-$158K |
3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$12.5K |
4 |
Two Sigma Investments
New York
|
-$6.61K |
5 |
UBS Group
Zurich,
Switzerland
|
-$4.74K |